SG11201809575TA - Biocatalysts and methods for hydroxylation of chemical compounds - Google Patents

Biocatalysts and methods for hydroxylation of chemical compounds

Info

Publication number
SG11201809575TA
SG11201809575TA SG11201809575TA SG11201809575TA SG11201809575TA SG 11201809575T A SG11201809575T A SG 11201809575TA SG 11201809575T A SG11201809575T A SG 11201809575TA SG 11201809575T A SG11201809575T A SG 11201809575TA SG 11201809575T A SG11201809575T A SG 11201809575TA
Authority
SG
Singapore
Prior art keywords
california
penobscot
rpm
international
air
Prior art date
Application number
SG11201809575TA
Other languages
English (en)
Inventor
Jovana Nazor
Robert Osborne
Jack Liang
Jonathan Vroom
Xiyun Zhang
David Entwistle
Rama Voladri
Ravi Garcia
Jeffrey Moore
Shane Grosser
Birgit Kosjek
Matthew Truppo
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of SG11201809575TA publication Critical patent/SG11201809575TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • C12P17/12Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG11201809575TA 2016-06-09 2017-04-19 Biocatalysts and methods for hydroxylation of chemical compounds SG11201809575TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662347724P 2016-06-09 2016-06-09
PCT/US2017/028370 WO2017213758A1 (en) 2016-06-09 2017-04-19 Biocatalysts and methods for hydroxylation of chemical compounds

Publications (1)

Publication Number Publication Date
SG11201809575TA true SG11201809575TA (en) 2018-11-29

Family

ID=60572322

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201809575TA SG11201809575TA (en) 2016-06-09 2017-04-19 Biocatalysts and methods for hydroxylation of chemical compounds

Country Status (6)

Country Link
US (4) US10184117B2 (zh)
EP (1) EP3469088B1 (zh)
CN (1) CN109715817B (zh)
IL (1) IL263448B2 (zh)
SG (1) SG11201809575TA (zh)
WO (1) WO2017213758A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109715817B (zh) * 2016-06-09 2022-12-09 科德克希思公司 用于化合物的羟基化的生物催化剂和方法
CN106834244B (zh) * 2016-11-04 2021-07-06 凯莱英医药集团(天津)股份有限公司 脯氨酸羟化酶及其应用
CN113046251B (zh) * 2019-12-27 2023-01-24 上海医药工业研究院 生产纽莫康定b0的基因工程菌、其制备方法及应用
CN113046250B (zh) * 2019-12-27 2023-01-24 上海医药工业研究院 生产纽莫康定b0的基因工程菌及其制备方法和应用
US11767519B2 (en) 2020-08-28 2023-09-26 Codexis, Inc. Engineered amylase variants
EP4204554A1 (en) 2020-08-28 2023-07-05 Codexis, Inc. Engineered protease variants
WO2022104385A2 (en) * 2020-11-13 2022-05-19 The Regents Of The University Of Colorado, A Body Corporate Stability and activity of enzymes by immobilization

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05130883A (ja) 1991-11-13 1993-05-28 Kyowa Hakko Kogyo Co Ltd トランス−l−ヒドロキシプロリンの製造法
KR100356926B1 (ko) 1993-09-07 2003-01-10 교와 핫꼬 고교 가부시끼가이샤 트랜스-4-히드록시-l-프롤린의제조법
US5962292A (en) 1993-09-07 1999-10-05 Kyowa Hakko Kogyo Co., Ltd. Process for producing cis-3-hydroxy-L-proline
US5854040A (en) 1993-09-07 1998-12-29 Kyowa Hakko Kogyo Co., Ltd. Process for producing trans-4-hydroxy-L-proline
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
ATE206460T1 (de) 1994-06-03 2001-10-15 Novo Nordisk Biotech Inc Gereinigte myceliophthora laccasen und nukleinsäuren dafür kodierend
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
KR0160191B1 (ko) 1995-08-12 1999-01-15 김광호 역광보정방법 및 그 장치
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
EP1007732B1 (en) 1997-01-17 2006-07-26 Maxygen, Inc. EVOLUTION OF procaryotic WHOLE CELLS BY RECURSIVE SEQUENCE RECOMBINATION
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
DK1036198T3 (da) 1997-12-08 2013-01-02 California Inst Of Techn Fremgangsmåde til fremstilling af polynukleotid- og polypeptidsekvenser
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
DE60044223D1 (de) 1999-01-19 2010-06-02 Maxygen Inc Durch oligonukleotide-vermittelte nukleinsäuren-rekombination
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
EP1165775A2 (en) 1999-03-05 2002-01-02 Maxygen, Inc. Recombination of insertion modified nucleic acids
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
EP1272967A2 (en) 2000-03-30 2003-01-08 Maxygen, Inc. In silico cross-over site selection
DK2315145T3 (en) 2002-03-01 2016-01-25 Codexis Mayflower Holdings Llc Methods, systems, and software for identifying the functional biomolecules
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
EP1488335A4 (en) 2002-03-09 2006-11-15 Maxygen Inc OPTIMIZING CROSSOVER POINTS FOR THE ADJUSTED EVOLUTION
EP1654354A1 (en) 2003-08-11 2006-05-10 Codexis, Inc. Improved ketoreductase polypeptides and related polynucleotides
US20090118130A1 (en) 2007-02-12 2009-05-07 Codexis, Inc. Structure-activity relationships
DK2666774T3 (en) 2008-01-18 2015-03-23 Merck Sharp & Dohme Beta-lactamase INHIBITORS
US8768871B2 (en) 2008-02-12 2014-07-01 Codexis, Inc. Method of generating an optimized, diverse population of variants
HUE034642T2 (en) 2008-02-12 2018-02-28 Codexis Inc A method for selecting an optimized diverse population of variants
FR2930553B1 (fr) 2008-04-29 2010-05-21 Novexel Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
EP2290065B1 (en) 2008-05-12 2014-08-27 Kyowa Hakko Bio Co., Ltd. Process for production of cis-4-hydroxy-l-proline
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
HUE029228T2 (en) 2008-06-13 2017-02-28 Codexis Inc A method for the synthesis of polynucleotide variants
US20120053350A1 (en) 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
DK3301208T3 (da) 2009-09-18 2020-12-14 Codexis Inc Reduceret codon-mutagenese
WO2013003290A1 (en) 2011-06-28 2013-01-03 Codexis, Inc. Protein variant generation by region shuffling
WO2013036861A1 (en) * 2011-09-08 2013-03-14 Codexis, Inc Biocatalysts and methods for the synthesis of substituted lactams
US20150050658A1 (en) 2012-03-15 2015-02-19 Codexix, Inc. Gene shuffling methods
US20150133698A1 (en) * 2012-04-20 2015-05-14 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
HUE042605T2 (hu) * 2012-05-08 2019-07-29 Codexis Inc Biokatalizátorok és kémiai vegyületek hidroxilálására szolgáló eljárások
BR112015018449B1 (pt) 2013-01-31 2022-05-31 Codexis, Inc Método implementado por computador para identificar moléculas biológicas tendo uma atividade desejada, meio de armazenamento lido por computador, e, sistema de computação
JP2014236713A (ja) * 2013-06-10 2014-12-18 協和発酵バイオ株式会社 ピペコリン酸水酸化酵素
US20150134315A1 (en) 2013-09-27 2015-05-14 Codexis, Inc. Structure based predictive modeling
WO2015098774A1 (ja) * 2013-12-26 2015-07-02 株式会社カネカ 光学活性環状イミノ酸の製造方法
US9611163B2 (en) 2014-03-05 2017-04-04 Owens-Brockway Glass Container Inc. Process and apparatus for refining molten glass
CN105177026A (zh) * 2015-09-22 2015-12-23 河北师范大学 一种顺式-3-羟基-l-脯氨酸羟化酶改造基因及其应用
CN109715817B (zh) * 2016-06-09 2022-12-09 科德克希思公司 用于化合物的羟基化的生物催化剂和方法
EP3536780A4 (en) * 2016-11-04 2020-06-17 Asymchem Laboratories (Tianjin) Co., Ltd. PROLINHYDROXYLASE AND APPLICATION THEREOF

Also Published As

Publication number Publication date
US20230272354A1 (en) 2023-08-31
EP3469088A1 (en) 2019-04-17
US10844358B2 (en) 2020-11-24
CN109715817A (zh) 2019-05-03
US20170355968A1 (en) 2017-12-14
US20210032605A1 (en) 2021-02-04
US10184117B2 (en) 2019-01-22
EP3469088B1 (en) 2023-09-06
US20190078061A1 (en) 2019-03-14
IL263448A (en) 2019-02-03
CN109715817B (zh) 2022-12-09
EP3469088C0 (en) 2023-09-06
EP3469088A4 (en) 2020-04-01
IL263448B2 (en) 2023-10-01
WO2017213758A1 (en) 2017-12-14
IL263448B1 (en) 2023-06-01
US11634695B2 (en) 2023-04-25

Similar Documents

Publication Publication Date Title
SG11201809575TA (en) Biocatalysts and methods for hydroxylation of chemical compounds
SG11201805835WA (en) Modified oncolytic virus
SG11201810210UA (en) Engineered botulinum neurotoxins
SG11201903857UA (en) Antibodies to pd-1 and uses thereof
SG11201900269XA (en) Channel sensing for independent links
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201407295YA (en) Biocatalysts and methods for hydroxylation of chemical compounds
SG11201805950UA (en) Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them
SG11201901528RA (en) Proteolytically cleavable chimeric polypeptides and methods of use thereof
SG11201803169WA (en) Cellulase variants and polynucleotides encoding same
SG11201807301SA (en) Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (dub) inhibitors
SG11201810522UA (en) Anti-cd40 antibodies and their uses
SG11201810485SA (en) Substituted carbonucleoside derivatives useful as anticancer agents
SG11201901797RA (en) Solid electrolyte
SG11201809499UA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201907685TA (en) Compositions and methods for robust dynamic metabolic control
SG11201907840RA (en) Fused imidazo-piperidine jak inhibitors
SG11201907474UA (en) Compositions useful in treatment of spinal muscular atrophy
SG11201908549RA (en) Automated quality control and spectral error correction for sample analysis instruments
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201909057YA (en) Compact wideband high gain circularly polarized antenna
SG11201407561UA (en) ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
SG11201806094SA (en) Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms
SG11201810486VA (en) High resistivity single crystal silicon ingot and wafer having improved mechanical strength
SG11201807005VA (en) Process for the separation of enantiomers of piperazine derivatives